A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

NCT07124117 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: OBI-902

Sponsor

OBI Pharma, Inc